BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 30801482)

  • 1. Demyelinating Neuropathy in a Patient Treated With Revusiran for Transthyretin (Thr60Ala) Amyloidosis.
    Zanazzi G; Arshad M; Maurer MS; Brannagan TH; Tanji K
    J Clin Neuromuscul Dis; 2019 Mar; 20(3):120-128. PubMed ID: 30801482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR).
    Judge DP; Kristen AV; Grogan M; Maurer MS; Falk RH; Hanna M; Gillmore J; Garg P; Vaishnaw AK; Harrop J; Powell C; Karsten V; Zhang X; Sweetser MT; Vest J; Hawkins PN
    Cardiovasc Drugs Ther; 2020 Jun; 34(3):357-370. PubMed ID: 32062791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The morphology of amyloid fibrils and their impact on tissue damage in hereditary transthyretin amyloidosis: An ultrastructural study.
    Koike H; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Sakurai T; Shimohata T; Katsuno M; Sobue G
    J Neurol Sci; 2018 Nov; 394():99-106. PubMed ID: 30243104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neuropathy in hereditary transthyretin amyloidosis: A narrative review.
    Tozza S; Severi D; Spina E; Iovino A; Aruta F; Ruggiero L; Dubbioso R; Iodice R; Nolano M; Manganelli F
    J Peripher Nerv Syst; 2021 Jun; 26(2):155-159. PubMed ID: 33960565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report.
    Yamamoto H; Hashimoto T; Kawamura S; Hiroe M; Yamashita T; Ando Y; Yokochi T
    J Med Case Rep; 2018 Dec; 12(1):370. PubMed ID: 30553273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac and peripheral vasomotor autonomic functions in late-onset transthyretin Val30Met familial amyloid polyneuropathy.
    Koike H; Nakamura T; Hashizume A; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Katsuno M; Sobue G
    J Neurol; 2017 Nov; 264(11):2293-2302. PubMed ID: 28983659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular autonomic functions in late-onset hereditary transthyretin amyloidosis with Val30Met mutation.
    Nakamura T; Koike H; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Katsuno M; Sobue G
    Amyloid; 2019; 26(sup1):6. PubMed ID: 31343341
    [No Abstract]   [Full Text] [Related]  

  • 8. Evolution of amyloid fibrils in hereditary transthyretin amyloidosis: an ultrastructural study.
    Koike H; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Katsuno M; Sobue G
    Amyloid; 2019; 26(sup1):26. PubMed ID: 31343346
    [No Abstract]   [Full Text] [Related]  

  • 9. Electrophysiological demyelinating features in hereditary ATTR amyloidosis.
    Ohashi N; Kodaira M; Morita H; Sekijima Y
    Amyloid; 2019 Mar; 26(1):15-23. PubMed ID: 30688105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ala97Ser transthyretin amyloidosis-associated polyneuropathy, clinical and neurophysiological profiles in a Thai cohort.
    Pasutharnchat N; Taychargumpoo C; Vorasettakarnkij Y; Amornvit J
    BMC Neurol; 2021 May; 21(1):206. PubMed ID: 34022837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transthyretin V122I amyloidosis with clinical and histological evidence of amyloid neuropathy and myopathy.
    Carr AS; Pelayo-Negro AL; Jaunmuktane Z; Scalco RS; Hutt D; Evans MR; Heally E; Brandner S; Holton J; Blake J; Whelan CJ; Wechalekar AD; Gillmore JD; Hawkins PN; Reilly MM
    Neuromuscul Disord; 2015 Jun; 25(6):511-5. PubMed ID: 25819286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and pathological findings in familial amyloid polyneuropathy caused by a transthyretin E61K mutation.
    Murakami T; Nishimura H; Nagai T; Hemmi S; Kutoku Y; Ohsawa Y; Sunada Y
    J Neurol Sci; 2017 Oct; 381():55-58. PubMed ID: 28991715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of cardiac transthyretin amyloidosis: an update.
    Emdin M; Aimo A; Rapezzi C; Fontana M; Perfetto F; Seferović PM; Barison A; Castiglione V; Vergaro G; Giannoni A; Passino C; Merlini G
    Eur Heart J; 2019 Dec; 40(45):3699-3706. PubMed ID: 31111153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of Tafamidis to Halt Progression of Ala36Pro TTR Oculomeningovascular Amyloidosis.
    Salvi F; Volpe R; Pastorelli F; Bianchi A; Vella A; Rapezzi C; Mascalchi M
    J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):e212-e214. PubMed ID: 29779881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schwann cell and endothelial cell damage in transthyretin familial amyloid polyneuropathy.
    Koike H; Ikeda S; Takahashi M; Kawagashira Y; Iijima M; Misumi Y; Ando Y; Ikeda SI; Katsuno M; Sobue G
    Neurology; 2016 Nov; 87(21):2220-2229. PubMed ID: 27794111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transthyretin Amyloidosis with Gastrointestinal Manifestation: a Case Report.
    Nakov R; Sarafov S; Nakov V; Gospodinova M; Todorov T; Kirov A; Todorova A; Tournev I
    J Gastrointestin Liver Dis; 2019 Sep; 28(3):359-361. PubMed ID: 31517333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life outcomes in APOLLO, the phase 3 trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis.
    Obici L; Berk JL; González-Duarte A; Coelho T; Gillmore J; Schmidt HH; Schilling M; Yamashita T; Labeyrie C; Brannagan TH; Ajroud-Driss S; Gorevic P; Kristen AV; Franklin J; Chen J; Sweetser MT; Wang JJ; Adams D
    Amyloid; 2020 Sep; 27(3):153-162. PubMed ID: 32131641
    [No Abstract]   [Full Text] [Related]  

  • 18. Patisiran Pharmacokinetics, Pharmacodynamics, and Exposure-Response Analyses in the Phase 3 APOLLO Trial in Patients With Hereditary Transthyretin-Mediated (hATTR) Amyloidosis.
    Zhang X; Goel V; Attarwala H; Sweetser MT; Clausen VA; Robbie GJ
    J Clin Pharmacol; 2020 Jan; 60(1):37-49. PubMed ID: 31322739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late-onset and fast progressive neuropathy and cardiomyopathy in Val32Ala transthyretin gene mutation.
    Cazzato D; Dalla Bella E; Saveri P; Taroni F; Marucci G; Lauria G
    Neurol Sci; 2019 Jun; 40(6):1267-1269. PubMed ID: 30685801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced intraepidermal nerve fibre density in patients with hereditary transthyretin amyloidosis.
    Masuda T; Ueda M; Misumi Y; Nomura T; Inoue Y; Isoguchi A; Kanenawa K; Tasaki M; Yamashita T; Sonoda Y; Obayashi K; Ando Y
    Amyloid; 2019; 26(sup1):79-80. PubMed ID: 31343297
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.